Related Experiment Video
Updated: Oct 26, 2025

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
New Developments in Exosomal lncRNAs in Cardiovascular Diseases
1Department of Geriatric Cardiology, Guangxi Key Laboratory Base of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention, Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Exosomal long non-coding RNAs (lncRNAs) are emerging biomarkers and therapeutic targets for cardiovascular diseases (CVDs). This review summarizes their roles and clinical potential in various CVDs.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Biochemistry
Background:
- Long non-coding RNAs (lncRNAs) are implicated in cardiovascular diseases (CVDs).
- Exosomes, secreted vesicles, mediate intercellular communication and carry various biomolecules, including lncRNAs.
- Exosomal lncRNAs are increasingly recognized for their significant roles in CVD pathogenesis.
Purpose of the Study:
- To review the current research on exosomal lncRNAs in various cardiovascular diseases.
- To explore the diagnostic and therapeutic potential of exosomal lncRNAs in CVDs.
- To discuss the challenges and future prospects of exosomal lncRNAs in clinical applications for CVD.
Main Methods:
- Literature review focusing on exosomal lncRNAs in atherosclerosis, myocardial infarction, ischemia-reperfusion injury, cardiac angiogenesis, aging, rheumatic heart disease, and CKD-CVD.
- Analysis of preclinical studies (animal and cell models) and clinical patient data.
- Synthesis of information on the diagnostic and therapeutic implications.
Main Results:
- Exosomal lncRNAs are involved in the progression of diverse cardiovascular conditions.
- Evidence from preclinical and clinical studies suggests their potential as diagnostic biomarkers.
- Exosomal lncRNAs show promise as therapeutic targets for cardiovascular diseases.
Conclusions:
- Exosomal lncRNAs represent a critical area of research in cardiovascular medicine.
- Their roles in CVDs highlight their potential for novel diagnostic and therapeutic strategies.
- Overcoming current challenges is crucial for the clinical translation of exosomal lncRNA-based therapies.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
05:30Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease II: Pathophysiology